A three-dimensional numerical model of a horizontal axis, energy extracting turbine : an implementation on a parallel computing system

In the last decade, there has been a resurgence of interest in tidal power as a renewable, and environmentally friendly source of electricity. Scotland is well placed in this regard, as the currents in the surrounding seas are primarily tidal; that is to say, driven by lunar and solar tides. Investigations into tidal streams as an energy source, their viability in particular locales, the efficient organisation of marine turbine farms, and most importantly, the effect of such farms on the environment, demand the use of computational fluid dynamics for effective modelling. They also require a turbine model sophisticated enough to generate realistic power output and wakes for a variety of flow conditions, yet simple enough to simulate a number of turbines on modest computing resources. What is presented here then, is the justification for such a model, the development and deployment of it during my PhD, and my validation of the model in a variety of environments

Turbulence characteristics in offshore wind farms from LES simulations of Lillgrund wind farm

AbstractThe effect of wind turbine wakes in large offshore wind energy arrays can be a substantial factor in affecting the performance of turbines inside the array. Turbulent mixing plays a key role in the wake recovery, having a significant effect on the length over which the wake is strong enough to affect the performance of other turbines significantly. We highlight how turbulence affects wind turbine wakes using results from LES simulations of Lillgrund offshore wind farm in the context of SCADA data selected to mirror the wind conditions simulated. The analysis here concentrated on temporal spectra of wind velocities measured by the turbine's nacelle anemometer and calculated at the turbine locations in the computational model. The effect of the wind turbine rotor on the downstream flow is quantified by analysing the change in spectral features of turbines within the wind farm compared to turbines at the side of the farm exposed to the wind

Independent theta phase coding accounts for CA1 population sequences and enables flexible remapping

Hippocampal place cells encode an animal's past, current, and future location through sequences of action potentials generated within each cycle of the network theta rhythm. These sequential representations have been suggested to result from temporally coordinated synaptic interactions within and between cell assemblies. Instead, we find through simulations and analysis of experimental data that rate and phase coding in independent neurons is sufficient to explain the organization of CA1 population activity during theta states. We show that CA1 population activity can be described as an evolving traveling wave that exhibits phase coding, rate coding, spike sequences and that generates an emergent population theta rhythm. We identify measures of global remapping and intracellular theta dynamics as critical for distinguishing mechanisms for pacemaking and coordination of sequential population activity. Our analysis suggests that, unlike synaptically coupled assemblies, independent neurons flexibly generate sequential population activity within the duration of a single theta cycle

Reconciling MOND and dark matter?

Observations of galaxies suggest a one-to-one analytic relation between the inferred gravity of dark matter at any radius and the enclosed baryonic mass, a relation summarized by Milgrom's law of modified Newtonian dynamics (MOND). However, present-day covariant versions of MOND usually require some additional fields contributing to the geometry, as well as an additional hot dark matter component to explain cluster dynamics and cosmology. Here, we envisage a slightly more mundane explanation, suggesting that dark matter does exist but is the source of MOND-like phenomenology in galaxies. We assume a canonical action for dark matter, but also add an interaction term between baryonic matter, gravity, and dark matter, such that standard matter effectively obeys the MOND field equation in galaxies. We show that even the simplest realization of the framework leads to a model which reproduces some phenomenological predictions of cold dark matter (CDM) and MOND at those scales where these are most successful. We also devise a more general form of the interaction term, introducing the medium density as a new order parameter. This allows for new physical effects which should be amenable to observational tests in the near future. Hence, this very general framework, which can be furthermore related to a generalized scalar-tensor theory, opens the way to a possible unification of the successes of CDM and MOND at different scales.Comment: 9 page

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

BACKGROUND: The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS: We evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform trial. Adult patients with Covid-19, within 24 hours after starting organ support in the intensive care unit (ICU), were randomly assigned to receive tocilizumab (8 mg per kilogram of body weight), sarilumab (400 mg), or standard care (control). The primary outcome was respiratory and cardiovascular organ support-free days, on an ordinal scale combining in-hospital death (assigned a value of -1) and days free of organ support to day 21. The trial uses a Bayesian statistical model with predefined criteria for superiority, efficacy, equivalence, or futility. An odds ratio greater than 1 represented improved survival, more organ support-free days, or both. RESULTS: Both tocilizumab and sarilumab met the predefined criteria for efficacy. At that time, 353 patients had been assigned to tocilizumab, 48 to sarilumab, and 402 to control. The median number of organ support-free days was 10 (interquartile range, -1 to 16) in the tocilizumab group, 11 (interquartile range, 0 to 16) in the sarilumab group, and 0 (interquartile range, -1 to 15) in the control group. The median adjusted cumulative odds ratios were 1.64 (95% credible interval, 1.25 to 2.14) for tocilizumab and 1.76 (95% credible interval, 1.17 to 2.91) for sarilumab as compared with control, yielding posterior probabilities of superiority to control of more than 99.9% and of 99.5%, respectively. An analysis of 90-day survival showed improved survival in the pooled interleukin-6 receptor antagonist groups, yielding a hazard ratio for the comparison with the control group of 1.61 (95% credible interval, 1.25 to 2.08) and a posterior probability of superiority of more than 99.9%. All secondary analyses supported efficacy of these interleukin-6 receptor antagonists. CONCLUSIONS: In critically ill patients with Covid-19 receiving organ support in ICUs, treatment with the interleukin-6 receptor antagonists tocilizumab and sarilumab improved outcomes, including survival. (REMAP-CAP ClinicalTrials.gov number, NCT02735707.)

RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer

In metastatic colorectal cancer, RAS and BRAF mutations cause resistance to anti-EGFR therapies, such as cetuximab. Heterogeneity in RAS and BRAF mutations might explain nonresponse in a subset of patients receiving cetuximab. Analyzing mutations in plasma-derived circulating tumor DNA (ctDNA) could provide a more comprehensive overview of the mutational landscape as compared to analyses of primary and/or metastatic tumor tissue. Therefore

Decalcification of Breast Cancer Bone Metastases with EDTA Does Not Affect ER, PR, and HER2 Results

In metastatic breast cancer (MBC), expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) guides treatment selection. In case of bone-only metastatic disease, ER, PR, and HER2 status assessment may be hampered by decalcification. We aimed to determine the optimal decalcification method, and to study discordance of receptor expression between paired primary breast tumors and optimally decalcified bone metastases. First, decalcification was simulated using acetic acid, hydrochloric/formic acid, and EDTA on 12 primary breast carcinomas. ER, PR, and HER2 immunohistochemistry (IHC) and HER2 in situ hybridization (ISH) were assessed, before and after the 3 decalcification methods. EDTA was considered t

Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis

The initial management of patients with suspected acute biliary infection starts with the measurement of vital signs to assess whether or not the situation is urgent. If the case is judged to be urgent, initial medical treatment should be started immediately including respiratory/circulatory management if required, without waiting for a definitive diagnosis. The patient's medical history is then taken; an abdominal examination is performed; blood tests, urinalysis, and diagnostic imaging are carried out; and a diagnosis is made using the diagnostic criteria for cholangitis/cholecystitis. Once the diagnosis has been confirmed, initial medical treatment should be started immediately, severity should be assessed according to the severity grading criteria for acute cholangitis/cholecystitis, and the patient's general status should be evaluated. For mild acute cholangitis, in most cases initial treatment including antibiotics is sufficient, and most patients do not require biliary drainage. However, biliary drainage should be considered if a patient does not respond to initial treatment. For moderate acute cholangitis, early endoscopic or percutaneous transhepatic biliary drainage is indicated. If the underlying etiology requires treatment, this should be provided after the patient's general condition has improved; endoscopic sphincterotomy and subsequent choledocholithotomy may be performed together with biliary drainage. For severe acute cholangitis, appropriate respiratory/circulatory management is required. Biliary drainage should be performed as soon as possible after the patient's general condition has been improved by initial treatment and respiratory/circulatory management. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also include